{
    "name": "inamrinone",
    "comment": "Rx",
    "other_names": [
        "amrinone"
    ],
    "classes": [
        "Inotropic Agents",
        "Phosphodiesterase Enzyme Inhibitors",
        "Nonselective"
    ],
    "source": "https://reference.medscape.com/drug/amrinone-inamrinone-342429",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: excretion in milk unknown; use with caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: excretion in milk unknown; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to inamrinone, milrinone and bisulfites"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Recent MI",
                "Electrolyte abnormalities",
                "Hypotension",
                "Proarrhythmic effects",
                "Insufficient cardiac filling pressure",
                "Severe aortic or pulmonic valvular diseas",
                "Renal impairment",
                "Concurrent use of disopyramide (may cause hypotension)"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "ozanimod",
            "description": {
                "common": "ozanimod increases toxicity of inamrinone by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Avoid or Use Alternate Drug. Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Monitor for hypertension with concomitant use."
            }
        },
        {
            "classification_type": "Serious",
            "interaction_with": "ponesimod",
            "description": {
                "common": "ponesimod, inamrinone.\nEither increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Consult cardiologist if considering treatment. Coadministration of ponesimod with drugs that decrease HR may have additive effects on decreasing HR and should generally not be initiated in these patients."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "anagrelide",
            "description": {
                "common": "anagrelide, inamrinone.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "milrinone",
            "description": {
                "common": "milrinone, inamrinone.\nEither increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor."
            }
        },
        {
            "classification_type": "Minor",
            "interaction_with": "digoxin",
            "description": {
                "common": "inamrinone, digoxin.\nEither increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Arrhythmia",
            "percent": "3"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "2.4"
        },
        {
            "name": "Nausea",
            "percent": "1.7"
        },
        {
            "name": "Hypotension",
            "percent": "1.3"
        },
        {
            "name": "Fever",
            "percent": "0.9"
        },
        {
            "name": "Vomiting",
            "percent": "0.9"
        },
        {
            "name": "Abdominal pain",
            "percent": "0.4"
        },
        {
            "name": "Anorexia",
            "percent": "0.4"
        },
        {
            "name": "Chest pain",
            "percent": "0.2"
        },
        {
            "name": "Injections site pain",
            "percent": "0.2"
        },
        {
            "name": "Hepatotoxicity",
            "percent": null
        },
        {
            "name": "rare",
            "percent": null
        }
    ]
}